MADRID, Spain and WALL, N.J., Sept. 07, 2022 (GLOBE NEWSWIRE) — BIO-key International, Inc. (NASDAQ: BKYI), an progressive supplier of workforce and buyer id and entry administration (IAM) options that includes Identity-Bound Biometrics (IBB), at the moment introduced that its EMEA (Europe, the Middle East, and Africa) business (previously Swivel Secure Europe) has deployed AuthControl Sentry for a number one Saudi Arabia Healthcare Procurement Provider in Riyadh, Saudi Arabia. The authentication answer will shield roughly 15,000 worker and provider customers with safe Multi-factor (MFA) entry with Single Sign-on (SSO) capabilities for all of its net and legacy purposes. The consumer is the biggest value-driven and centralized well being care procurement, re-exporting, warehousing, and distribution firm for prescription drugs, medical gear, and provides within the Kingdom of Saudi Arabia.
The goal of this undertaking was to centralize all net and authorized purposes in a unified portal to supply workers and suppliers throughout the Middle East with safe entry to purposes. Using the AuthControl Sentry answer will scale back password reset requests by eradicating the necessity for authentication to 4 or 5 completely different purposes sometimes required to ship a pharmaceutical or medical package deal by a courier.
“We are proud to help streamline the procurement process for one of the largest and most trusted suppliers to hospitals, clinics, and pharmacies in Saudi Arabia and the Middle East. Secure, reliable authentication is vital for delivering urgent medicines to patients in need. Reducing time and friction in the authentication process can improve the delivery of healthcare services and even save lives. For example, authentication for four common software applications that took an average of four minutes before has been reduced to just one minute using our AuthControl Sentry solution. This solution saves time and increases the productivity and reliability of healthcare procurement processes,” stated Alex Rocha, Managing Director, BIO-key EMEA.
About BIO-key International, Inc. (www.bio-key.com)
BIO-key has over 20 years of experience in offering authentication expertise for 1000’s of organizations and tens of millions of customers and is revolutionizing authentication with biometric-centric, multi-factor id and entry administration (IAM) options, together with its PortalGuard IAM answer that gives handy and safe entry to units, data, purposes, and high-value transactions. BIO-key’s patented software program and {hardware} options, with industry-leading biometric capabilities, allow large-scale on-premises and cloud-based Identity-as-a-Service (IDaaS) options and customised enterprise options. Swivel Secure Europe, S.A, is a 100% owned BIO-key IAM options supplier based mostly in Madrid, Spain, that serves the European, Middle East, and African markets.
BIO-key Safe Harbor Statement
All statements contained on this press launch apart from statements of historic info are “forward-looking statements” as outlined within the Private Securities Litigation Reform Act of 1995 (the “Act”). The phrases “estimate,” “project,” “intends,” “expects,” “anticipates,” “believes,” and comparable expressions are supposed to establish forward-looking statements. Such forward-looking statements are made based mostly on administration’s beliefs, in addition to assumptions made by, and knowledge at the moment accessible to, administration pursuant to the “safe harbor” provisions of the Act. These statements should not ensures of future efficiency or occasions and are topic to dangers and uncertainties which will trigger precise outcomes to vary materially from these included inside or implied by such forward-looking statements. These dangers and uncertainties embrace, with out limitation, our historical past of losses and restricted income; our capability to lift extra capital; our capability to guard our mental property; adjustments in business circumstances; adjustments in our gross sales technique and product improvement plans; adjustments within the market; continued companies of our government administration crew; safety breaches; competitors within the biometric expertise {industry}; market acceptance of biometric merchandise typically and our merchandise below improvement; the length and severity of the present coronavirus COVID-19 pandemic and its impact on our business operations, gross sales cycles, personnel, and the geographic markets by which we function; delays within the improvement of merchandise and statements of assumption underlying any of the foregoing in addition to different elements set forth below the caption see “Risk Factors” in our Annual Report on Form 10-K for the year ended December 31, 2021 and other filings with the Securities and Exchange Commission. Readers are cautioned not to place undue reliance on these forward-looking statements, which speak only as of the date made. Except as required by law, the Company undertakes no obligation to disclose any revision to these forward-looking statements whether as a result of new information, future events, or otherwise. Additionally, there may be other factors of which the Company is not currently aware that may affect matters discussed in forward-looking statements and may also cause actual results to differ materially from those discussed. In particular, the consequences of the coronavirus outbreak to economic conditions and the industry in general and the financial position and operating results of our Company, in particular, have been material, are changing rapidly, and cannot be predicted.
Engage with BIO-key:
Facebook – Corporate: https://www.facebook.com/BIOkeyInternational/
LinkedIn – Corporate: https://www.linkedin.com/company/bio-key-international
Twitter – Corporate: @BIOkeyIntl
Twitter – Investors: @BIO_keyIR
StockTwits: BIO_keyIR
BIO-key Media Contact:
Erin Knapp
Matter Communications
[email protected]
914-260-3158
Investor Contacts:
William Jones, David Collins
Catalyst IR
[email protected]
212-924-9800
